Published in Cancer Weekly, May 19th, 2009
"We compiled a study group of 24 patients < 40 years of age with colorectal carcinoma, and 45 patients >= 40 years of age served as controls. Cases were evaluated for clinical risk factors of malignancy and pathologic Features predictive of outcome. The tumors were immunohistochemically stained for O-6-methylguanine methyltransferase, MLH-1, MSH-2, MSH-6, beta-catenin,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.